拓宽帕金森病的危险因素、共病与前驱特征谱
基于德国法定医保门诊索赔数据的病例对照研究,纳入2011年1月1日至2020年12月31日期间138345例新发帕金森病患者并按1:2匹配对照,分析与帕金森病相关的危险因素、共病及前驱特征,发现多种因素与帕金森病诊断相关,部分关联在诊断前5至10年即存在。
要点
- 不宁腿综合征、癫痫、双相障碍和精神分裂症与帕金森病诊断的关联较强,比值比分别为4.19、2.26、3.81和4.48。
- 嗅觉缺失、震颤、快动眼睡眠行为障碍等前驱特征与帕金森病诊断相关,部分关联在诊断前5至10年即可观察到。
- 听力下降、皮脂溢性皮炎、胃食管反流及1型和2型糖尿病等也与帕金森病诊断存在关联。
核心结论
- 这项病例对照研究提示,在具有代表性的人群中,帕金森病与某些危险因素、共病和前驱症状之间的关联可能反映帕金森病早期纹状体外和脑外病理。
研究设计与样本
- 采用德国法定医保2011年1月1日至2020年12月31日门诊就诊索赔数据的病例对照研究。
- 纳入新发帕金森病且既往无帕金森综合征或痴呆诊断的患者,对照按年龄、性别、地区和最早门诊就诊年份1:2匹配。
- 共纳入138345例新发帕金森病患者(平均[标准差]年龄75.1[9.8]岁;男性73720例[53.3%])和276690例匹配对照(平均[标准差]年龄75.1[9.8]岁;男性147440例[53.3%])。
- 研究参与者平均(标准差)随访6.0(2.0)年。
主要发现
- 与帕金森病相关的危险因素和前驱特征包括:创伤性脑损伤比值比1.62(95%置信区间1.36-1.92)、酒精滥用比值比1.32(95%置信区间1.21-1.44)、高血压比值比1.29(95%置信区间1.26-1.31)、嗅觉缺失比值比2.16(95%置信区间1.59-2.93)、异态睡眠(包括快动眼睡眠行为障碍)比值比1.62(95%置信区间1.42-1.84)。
- 此外,与不宁腿综合征(比值比4.19;95%置信区间3.91-4.50)、睡眠呼吸暂停(比值比1.45;95%置信区间1.37-1.54)、癫痫(比值比2.26;95%置信区间2.07-2.46)、偏头痛(比值比1.21;95%置信区间1.12-1.29)、双相障碍(比值比3.81;95%置信区间3.11-4.67)和精神分裂症(比值比4.48;95%置信区间3.82-5.25)存在关联。
- 以下诊断也与帕金森病相关:嗅觉缺失以外的感觉损害,如听力下降(比值比1.14;95%置信区间1.09-1.20)和皮肤感觉改变(比值比1.31;95%置信区间1.21-1.43)。
- 还与皮肤疾病(如皮脂溢性皮炎比值比1.30;95%置信区间1.15-1.46;银屑病比值比1.13;95%置信区间1.05-1.21)、胃肠道疾病(如胃食管反流比值比1.29;95%置信区间1.25-1.33;胃炎比值比1.28;95%置信区间1.24-1.33)、潜在炎症成分的疾病(如血清阴性骨关节炎比值比1.21;95%置信区间1.03-1.43)以及1型糖尿病(比值比1.32;95%置信区间1.21-1.43)和2型糖尿病(比值比1.24;95%置信区间1.20-1.27)存在正相关。
- 诊断前5至10年即存在的关联包括震颤(比值比4.49;95%置信区间3.98-5.06)、不宁腿综合征(比值比3.73;95%置信区间3.39-4.09)、双相障碍(比值比3.80;95%置信区间2.82-5.14)和精神分裂症(比值比4.00;95%置信区间3.31-4.85)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: The prodromal phase of Parkinson disease (PD) may last for more than 10 years. Recognition of the spectrum and occurrence of risk factors, comorbidities, and prodromal features of PD can increase understanding of the causes and development of the disease and help identify individuals at risk. OBJECTIVE: To identify the association of a subsequent diagnosis of PD with a range of risk factors and prodromal features, including lifestyle factors, comorbidities, and potential extracerebral manifestations of PD. DESIGN, SETTING, AND PARTICIPANTS: This was a case-control study using insurance claims of outpatient consultations of patients with German statutory health insurance between January 1, 2011, and December 31, 2020. Included were patients with incident diagnosis of PD without a previous diagnosis of parkinsonism or dementia and controls matched 1:2 for age, sex, region, and earliest year of outpatient encounter. EXPOSURES: Exposures were selected based on previous systematic reviews, case-control and cohort studies reporting on risk factors, comorbidities, and prodromal features of PD. MAIN OUTCOMES AND MEASURES: Previously postulated risk factors and prodromal features of PD, using the International Statistical Classification of Diseases and Related Health Problems, Tenth Revision (ICD-10) coding. RESULTS: A total of 138 345 patients with incident PD (mean [SD] age, 75.1 [9.8] years; 73 720 male [53.3%]) and 276 690 matched controls (mean [SD] age, 75.1 (9.8) years; 147 440 male [53.3%]) were identified. Study participants were followed up for a mean (SD) of 6.0 (2.0) years. Consistent with previous reports, risk factors and prodromal features associated with PD included traumatic brain injury, odds ratio (OR), 1.62; 95% CI, 1.36-1.92; alcohol misuse, OR, 1.32; 95% CI, 1.21-1.44; hypertension, OR, 1.29; 95% CI, 1.26-1.31; anosmia, OR, 2.16; 95% CI, 1.59-2.93; and parasomnias (including RBD), OR, 1.62; 95% CI, 1.42-1.84. In addition, there were associations with restless legs syndrome (OR, 4.19; 95% CI, 3.91-4.50), sleep apnea (OR, 1.45; 95% CI, 1.37-1.54), epilepsy (OR, 2.26; 95% CI, 2.07-2.46), migraine (OR, 1.21; 95% CI, 1.12-1.29), bipolar disorder (OR, 3.81; 95% CI, 3.11-4.67), and schizophrenia (OR, 4.48; 95% CI, 3.82-5.25). The following diagnoses were also found to be associated with PD: sensory impairments beyond anosmia, such as hearing loss (OR, 1.14; 95% CI, 1.09-1.20) and changes of skin sensation (OR, 1.31; 95% CI, 1.21-1.43). There were also positive associations with skin disorders (eg, seborrheic dermatitis, OR, 1.30; 95% CI, 1.15-1.46; psoriasis, OR, 1.13; 95% CI, 1.05-1.21), gastrointestinal disorders (eg, gastroesophageal reflux, OR, 1.29; 95% CI, 1.25-1.33; gastritis, OR, 1.28; 95% CI, 1.24-1.33), conditions with a potential inflammatory component (eg, seronegative osteoarthritis, OR, 1.21; 95% CI, 1.03-1.43), and diabetes types 1 (OR, 1.32; 95% CI, 1.21-1.43) and 2 (OR, 1.24; 95% CI, 1.20-1.27). Associations even 5 to 10 years before diagnosis included tremor (odds ratio [OR], 4.49; 95% CI, 3.98-5.06), restless legs syndrome (OR, 3.73; 95% CI, 3.39-4.09), bipolar disorder (OR, 3.80; 95% CI, 2.82-5.14), and schizophrenia (OR, 4.00; 95% CI, 3.31-4.85). CONCLUSIONS AND RELEVANCE: Results of this case-control study suggest that the associations found between PD and certain risk factors, comorbidities, and prodromal symptoms in a representative population may reflect possible early extrastriatal and extracerebral pathology of PD. This may be due to shared genetic risk with PD, medication exposure, or direct causation, or represent pathophysiologically relevant factors contributing to the pathogenesis of PD.
引用
- Schrag A, Bohlken J, Dammertz L, et al. Widening the Spectrum of Risk Factors, Comorbidities, and Prodromal Features of Parkinson Disease. JAMA Neurol. 2023. PMID: 36342675. doi:10.1001/jamaneurol.2022.3902
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。